1Russmann B,de Wit M,Kroger N,et al. Haemopoietic cell transplantation of patients with a history of deep or invasire fungal infection during prophylaxis with liposomal amphotericin B[J]. Acta Haematol, 2005,113(2) : 104
2Karthaus M,Cornely O. Recent developments in the management of invasive fungal infections in patients with hematological malignancies[J ]. Ann Haematol, 2005,84 (2) ; 207.
3Koldehoff M,Zaktzewski Jl. Modern management of respiratory failure due to pulmonary mycoses following allogeneic haematopoietic stem cells transplantation [J]. Am J Haematol,2005,79(2) :158.
4Badiee P, KordbachehP, Alborzi A, et al. Fungal infections in solid organ recipients[J]. Exp Clin Transplant, 2005,3(3) :385.
5Gulbahce HE, Pambuccian SE, Jessuran J, et al. Pulmonacy nodular lesions in bone marrow transplant recipients: impact of histologic diagnosis on patient manage ment and prognosis[J]. Am J Clin Patho, 2004,121 (2) 205.
6Jones BL,Mclintock LA. Impact of diagnostic markers on early antifungal therapy[J]. Curr Opin Infect Dis, 2003, 16(3) :521.
7Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography,based preemptive antifungal therapy in neutropenic patient at high risk for invasive fungal infection., a prospective feasibility study[J]. Clin Infect Dis, 2005,41 (8): 1242.
8Sanguinetti MB, Posteraro L, Pagano G, et al. Comparison of real-time PCR conventional PCR and galactomann antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis[J]. J Clin Microbiol, 2003,41 (10) : 3922.
9Stephane B,Jean-Marc C. Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis[J]. Immunol Med Microbiol,2005,45(3) : 361.
10Iwen PC,Freifeld AG,Bruening TA,et al. Use of a panfungal PCR assay for detection of fungal pathogens in a commercial blood culture system[J]. J Clin Microbiol, 2004,42(5) :2292.
